IKAN BIOTECH 

Zebrafish cancer patient avatars

OWNER

Ruben Diez (See Profile)


Sector

Biotech

Stage

Development, market readiness, clinical trial

Country

Spain


Our ZebraONCOfish platform allow us to develop cancer patients avatars, using zebrafish as an in vivo model.

We are developing a library of at least 300 biopsies of digestive tract cancer patients.

The FDA has signed a MOU where it accepts zebrafish according to regulations in preclinical phases for toxicity assays.

Status

–

IP Type

Trade secret

Time

–

Countries

Coverage

We are implementing the trade secret to protect not only the biopsy culture cells protocols but also the microinjection and analysis of the results.

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 7th of May 2023

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar